NCT06351527
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06351527
Title Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors InnoCare Pharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
BRCR Medical Center RECRUITING Plantation Florida 33322 United States Details
Clinical Research Alliance RECRUITING Westbury New York 11590 United States Details
Pan American Center for Oncology Trials RECRUITING San Juan 00935 Puerto Rico Details
CNE CCOHTPC of Cherkasy Regional Council RECRUITING Cherkasy 18009 Ukraine Details
CNE"City Clin Hosp#4"of Dnipro City Council RECRUITING Dnipro 49102 Ukraine Details
Medical Center of Limited Liability Company Arensia Exploratory Medicine RECRUITING Kyiv 1135 Ukraine Details
Med Center 'Ok!Clinic+' of International Institute of Clinical Trials LLC RECRUITING Kyiv 2091 Ukraine Details
SI Institute of Blood Pathology and Transfusion Medicine of AMSU RECRUITING Lviv 79057 Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field